The oncogene Yes-associated protein (YAP) and its paralogue Transcriptional Co-Activator With PDZ-binding Motif (TAZ or WWTR1) have been considered as attractive pharmacological targets, as they are highly activated in many forms of cancers and contribute to tumor growth and invasion (39). This evidence concerns the gene YAP1 and neoplasm.